PURPOSE: A primary aim was to assess the relative contribution of psychological factors, such as anxiety, depression and mental adjustment to cancer, to overall survival outcomes at a median follow-up of 2 years following allogeneic haematopoietic stem cell transplant (HSCT). A secondary aim was to ascertain if demographic, medical and psychosocial factors assessed prior to transplantation were predictors of survival for patients after accounting for post-transplant events. METHOD: Between 2005 and 2011, 130 allograft patients completed the Mental Adjustment to Cancer Scale and Brief Symptom Inventory-18 as part of routine psychological assessment before undergoing transplantation. Survival status data were obtained, and predictors of survival status assessed and analysed using Cox-regression models. RESULTS: Thirteen percent experienced clinical levels of distress pre-transplant. None of the psychological factors predicted post-HSCT survival. In contrast, hierarchical multivariate analysis indicated that post-transplant factors (acute graft-versus-host disease and relapse post-transplant) predicted survival (Chi-square change, p < 0.001). The addition of a series of pre-transplant psychosocial and medical variables further improved the prediction of survival (Chi-square change, p = 0.01). In particular, relationship status (being single) (p = 0.04) and increased somatic symptoms (p = 0.02) pre-transplant were associated with shorter survival. Both variables were not associated with medical factors but were related to increased severity of anxiety and depressive symptoms as well as greater use of helpless-hopelessness and reduced fighting spirit adjustment response. CONCLUSIONS: Despite the significant influence of acute post-transplant factors in predicting survival following allogeneic HSCT, multidisciplinary pre-transplant assessments are important in identifying patients who are likely to experience poorer survival outcomes.
PURPOSE: A primary aim was to assess the relative contribution of psychological factors, such as anxiety, depression and mental adjustment to cancer, to overall survival outcomes at a median follow-up of 2 years following allogeneic haematopoietic stem cell transplant (HSCT). A secondary aim was to ascertain if demographic, medical and psychosocial factors assessed prior to transplantation were predictors of survival for patients after accounting for post-transplant events. METHOD: Between 2005 and 2011, 130 allograft patients completed the Mental Adjustment to Cancer Scale and Brief Symptom Inventory-18 as part of routine psychological assessment before undergoing transplantation. Survival status data were obtained, and predictors of survival status assessed and analysed using Cox-regression models. RESULTS: Thirteen percent experienced clinical levels of distress pre-transplant. None of the psychological factors predicted post-HSCT survival. In contrast, hierarchical multivariate analysis indicated that post-transplant factors (acute graft-versus-host disease and relapse post-transplant) predicted survival (Chi-square change, p < 0.001). The addition of a series of pre-transplant psychosocial and medical variables further improved the prediction of survival (Chi-square change, p = 0.01). In particular, relationship status (being single) (p = 0.04) and increased somatic symptoms (p = 0.02) pre-transplant were associated with shorter survival. Both variables were not associated with medical factors but were related to increased severity of anxiety and depressive symptoms as well as greater use of helpless-hopelessness and reduced fighting spirit adjustment response. CONCLUSIONS: Despite the significant influence of acute post-transplant factors in predicting survival following allogeneic HSCT, multidisciplinary pre-transplant assessments are important in identifying patients who are likely to experience poorer survival outcomes.
Authors: Ji Eun Park; Kyung Im Kim; Sung Soo Yoon; Bong Jin Hahm; Sang Min Lee; Jeong Hyun Yoon; Wan Gyoon Shin; Hye Suk Lee; Jung Mi Oh Journal: Pharmacotherapy Date: 2010-12 Impact factor: 4.705
Authors: Daniel R Richardson; Ying Huang; Heather L McGinty; Patrick Elder; Joanna Newlin; Cyndi Kirkendall; Leslie Andritsos; Don Benson; William Blum; Yvonne Efebera; Sam Penza; Craig Hofmeister; Samantha Jaglowski; Rebecca Klisovic; Sumithira Vasu; Basem William; Steven Devine; Ashley E Rosko Journal: Bone Marrow Transplant Date: 2018-02-14 Impact factor: 5.483
Authors: Emily A Rosenthal; Pei-Shu Ho; Galen O Joe; Sandra A Mitchell; Susan Booher; Steven Z Pavletic; Kristin Baird; Edward W Cowen; Leora E Comis Journal: Support Care Cancer Date: 2019-12-06 Impact factor: 3.603
Authors: Timothy S Sannes; Teresa L Simoneau; Susan K Mikulich-Gilbertson; Crystal L Natvig; Benjamin W Brewer; Kristin Kilbourn; Mark L Laudenslager Journal: Support Care Cancer Date: 2018-10-24 Impact factor: 3.603
Authors: Anureet C Copeland; Xianming Tan; Rebekah P Nash; Emily G Holmes; Janell Markey; Thomas C Shea; William A Wood; Eliza M Park Journal: Psychooncology Date: 2020-09-11 Impact factor: 3.894
Authors: Kelly E Rentscher; Judith E Carroll; Mark B Juckett; Christopher L Coe; Aimee T Broman; Paul J Rathouz; Peiman Hematti; Erin S Costanzo Journal: J Natl Cancer Inst Date: 2021-10-01 Impact factor: 13.506
Authors: K B Ehrlich; G E Miller; T Scheide; S Baveja; R Weiland; J Galvin; J Mehta; F J Penedo Journal: Bone Marrow Transplant Date: 2016-07-18 Impact factor: 5.174